Evidence map›Paper›PMID 41947983›Full record

ArticleWomen2026

A Pilot and Feasibility Study of Combined Oral Contraceptive Pills and Metabolic Outcomes in Premenopausal Women with Overweight or Obesity.

Adnin Zaman, Aaron Lazorwitz, Myla Strawderman, Hong Hong Liu, Sarah A Tydings, Susan W Groth, Victoria A Catenacci, Elizabeth A Thomas

Abstract read
In one paragraph

Article in Women, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Adnin ZamanDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.ORCID 0000-0002-6884-7748
Aaron LazorwitzDivision of Complex Family Planning, Department of Obstetrics, Gynecology & Reproductive Sciences, Yale University, New Haven, CT 06510, USA.ORCID 0000-0003-0208-8432
Myla StrawdermanDepartment of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY 14642, USA.ORCID 0000-0002-6016-968X
Hong Hong LiuDepartment of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY 14642, USA.
Sarah A TydingsUniversity of Rochester School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY 14642, USA.
Susan W GrothSchool of Nursing, University of Rochester Medical Center, Rochester, NY 14642, USA.ORCID 0000-0002-3672-7696
Victoria A CatenacciDivision of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Center, Aurora, CO 80045, USA.
Elizabeth A ThomasDivision of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Center, Aurora, CO 80045, USA.

Funding

NIH Prior Approval Process ProfessionalUL1TR002535 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2018 to 2022
$51.1M
Training the Next Generation of Innovative and Collaborative Patient-Oriented Researchers to Reduce Obesity and Improve Cardiometabolic HealthK24HL169755 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI VICTORIA A CATENACCI · 2023 to 2026
$504k
The Impact of Combined Hormonal Contraceptive Use on Weight Loss in Pre-Menopausal Women Enrolled in a Behavioral Weight Loss TrialF32DK123878 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI ZAMAN, ADNIN · 2020 to 2022
$233k
NCATS NIH HHS UL1 TR002535NHLBI NIH HHS K24 HL169755NIDDK NIH HHS F32 DK123878
6 · The paper itself

Abstract

Combined oral contraceptive pills (COCPs) are commonly used by reproductive-aged women with overweight or obesity, but their metabolic effects remain understudied. This pilot study examined the feasibility of recruiting and retaining women with overweight or obesity initiating COCPs and evaluated changes in body weight, body composition, energy intake (EI), eating behaviors, and cardiometabolic markers. Premenopausal women aged 18-40 years with a body mass index between 25 and 45 kg/m

Indexed as

appetitebody weightcombined oral contraceptionfeasibilitynonhormonal contraceptionobesitypilot

Identifiers

PMID41947983
PMCPMC13052517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.